Scott Lunin is an Oncology physician affiliated with Florida Cancer Specialists & Research Institute. OpenAlex indexes 31 publications with 1,321 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1675 Bay Harbor Ln
Sarasota, FL 342313041
Telephone
941-626-2154Provider last certified this registry record 29 May 2026.
Industry payments
57 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year202522 payments
- PFIZER INC.Program year202511 payments
- Merck Sharp & Dohme LLCProgram year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
30%PD-1 inhibitor23.6%Pembrolizumab100%Part B, office-administered≥25 patientsMicrotubule Inhibitor5.1%Paclitaxel100%Part B, office-administered≥11 patients+ 8 more classes in this area
Blood & clotting
29.3%Erythropoiesis-stimulating Agent15.2%Epoetin alfa100%Part B, office-administered≥41 patientsParenteral Iron Replacement8.5%Iron sucrose100%Part B, office-administered≥12 patients+ 3 more classes in this area
Metabolism & gastrointestinal
19.9%Substance P/Neurokinin-1 Receptor Antagonist11.7%Aprepitant100%Part B, office-administered≥26 patientsOther antiemetics5.6%Fosaprepitant100%Part B, office-administered≥12 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Bradley Monk, MD
Florida Cancer Specialists & Research Institute
Satish Shanbhag, MD, MPH
Florida Cancer Specialists & Research Institute
Ivor Percent, MD
Florida Cancer Specialists & Research Institute
Bradford Perez, MD
Florida Cancer Specialists & Research Institute
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”